|
|
|
|
|
|
Neurocrine Bioscienc (NBIX)
|
|
59.42 -1.45 (-2.38%)
|
10/18/2017 4:00pm
|
|
Open:
|
61.53
|
Pre. Close:
|
60.87
|
|
High:
|
61.66
|
Low:
|
59.35
|
|
Volume:
|
652,848
|
Market Cap:
|
5.24B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
62.3 - 63.34
|
63.34 - 64.58
|
|
Low:
|
56.66 - 57.63
|
57.63 - 58.79
|
|
Close:
|
57.84 - 59.2
|
59.2 - 60.82
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-18 4:43:35 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 70.99  One year: 74.48
|
|
Support:
|
Support1: 55.95 Support2: 46.55
|
|
Resistance:
|
Resistance1:
60.78 Resistance2: 63.77
|
|
Pivot:
|
61.62 
|
|
Moving Averages:
|
MA(5): 61.18 MA(20): 60.86
MA(100): 52.12 MA(250): 48.19
|
|
MACD:
|
MACD(12,26):
1.15 Signal(12,26,9): 1.58
|
|
%K %D:
|
%K(14,3): 44.25 %D(3): 60.37
|
|
RSI:
|
RSI(14): 47.36
|
|
52-Week:
|
High: 63.77
Low: 37.35 Change(%): 30.1
|
|
Average Vol(K):
|
3-Month: 79952
10-Days 36393
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.NBIX has closed below the lower band by 5.1%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 41.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to NBIX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Wed, 16 Aug 2017 15:33:45 GMT
Neurocrine Biosciences: Ingrezza's Strong Launch, Pipeline To Create Value
Fri, 04 Aug 2017 14:48:45 GMT
Neurocrine Biosciences Off To A Good Start With Ingrezza
Mon, 14 Aug 2017 13:07:30 GMT
This Could Be A Game-Changing Month For Neurocrine Biosciences
Thu, 05 Oct 2017 11:03:45 GMT
Neurocrine Announces FDA Approval of 80 mg INGREZZA® (valbenazine) Capsules ...
Mon, 16 Oct 2017 17:15:00 GMT
How Is Neurocrine Biosciences Positioned Now?
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
